Clinical Trials Logo

Herpes Zoster clinical trials

View clinical trials related to Herpes Zoster.

Filter by:

NCT ID: NCT03120364 Completed - Herpes Zoster Clinical Trials

Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Start date: September 9, 2015
Phase: Phase 3
Study type: Interventional

This study assesses non-inferiority by comparing GMR(Geometric Mean Ratio) of NBP608 to Zostavax which are evaluated by gpELISA (Glycoprotein Enzyme Linked Immunosorbent Assay). Total of 824 healthy subjects (412 subjects per treatment arm) aged 50 and over are enrolled, and each subject is administered with single dose of vaccine which is randomly assigned.

NCT ID: NCT03116594 Completed - Herpes Zoster Clinical Trials

Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Start date: January 3, 2014
Phase: Phase 2/Phase 3
Study type: Interventional

This study assesses non-inferiority by comparing GMR(Geometric Mean Ratio) of NBP608 to Zostavax which are evaluated by gpELISA (Glycoprotein Enzyme Linked Immunosorbent Assay). Total of 646 healthy subjects aged 50 and over are enrolled, and each subject is administered with single dose of vaccine which is randomly assigned.

NCT ID: NCT03114982 Completed - Varicella Clinical Trials

The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age

Start date: May 2016
Phase: Phase 2
Study type: Interventional

This study evaluates the immunogenicity and safety of three different potencies of NBP608 and Varivax which are indicated for active immunization for the prevention of varicella. Total of 152 subjects (38 subjects per each treatment arm) of 12 months to 12 years of age are enrolled, and each subject is administered with single dose of vaccine which is randomly assigned.

NCT ID: NCT03114943 Completed - Varicella Clinical Trials

Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age

Start date: July 14, 2016
Phase: Phase 3
Study type: Interventional

This study assesses non-inferiority by comparing seroconversion rate of NBP608 to Varivax which are indicated for active immunization for prevention of varicella. Total of 488 subjects (244 subjects per treatment arm) of 12 months to 12 years of age are enrolled, and each subject is administered with single dose of vaccine which is randomly assigned.

NCT ID: NCT03066037 Completed - Chronic Pain Clinical Trials

Regional-anaesthesiological Infiltration Techniques for the Management of Chronic Pain: a Retrospective Study

RetroBlock
Start date: January 1, 2009
Phase: N/A
Study type: Observational

There is a significant debate whether local infiltration techniques may be a method to treat complicated chronic pain syndromes, e.g. refractory headache. Until now there is a lack of evidence regarding efficacy of this treatment especially in long term follow up. Similarly, indication and management are under debate. Aim of this trial is to analyse pain scores during first treatment with anaesthesiological infiltration series.

NCT ID: NCT02981836 Completed - Varicella Clinical Trials

A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines

Start date: August 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the protective effect, safety and immunogenicity of a live attenuated varicella vaccine in healthy children.

NCT ID: NCT02979639 Completed - Herpes Zoster Clinical Trials

Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age

Start date: January 16, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the impact of reactogenicity of GSK Biologicals' HZ/su vaccine on Quality of Life (QoL) in adults ≥ 50 years of age

NCT ID: NCT02965404 Completed - Varicella Clinical Trials

A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children

Start date: April 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety of a live attenuated varicella vaccine in healthy adults, adolescents, and children.

NCT ID: NCT02958345 Completed - Herpes Zoster Clinical Trials

Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™

Start date: June 2013
Phase: Phase 4
Study type: Interventional

Study Design: Double-blinded, placebo controlled study of the efficacy of Zostavax in cirrhosis. Subjects will receive either Zostavax or placebo and will be followed for four months. Hypothesis: The investigators hypothesize Zostavax would induce cell-based immunity in cirrhotic patients like that seen in elderly patients.

NCT ID: NCT02902822 Completed - Melanoma Clinical Trials

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

Start date: October 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the validity and utility of a tele-dermatology system in the midterm periodic screening of non-widespread skin lesions of recent onset or for which a specialized early classification is deemed to change the prognosis - including precancerous skin lesions as well as melanoma and non-melanoma skin cancers - compared to control visits at fixed follow-up.